Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Title
Intervention Indication Therapeutic Area Year Actions
Obecabtagene autoleucel for treating refractory or relapsed B cell acute lymphoblastic leukaemia Obecabtagene autoleucel Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2023 View  |  Download
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis Mycophenolate mofetil (Cellcept) , Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) Lupus nephritis Immunology , Nephrology 2023 View  |  Download
Ocrelizumab (subcutaneous) for the treatment of primary progressive or relapsing multiple sclerosis Ocrelizumab (Ocrevus;2H7v114) Multiple sclerosis (MS) Neurology 2023 View  |  Download
Olorofim for invasive fungal infections Olorofim Fungal infections Infectious Disease 2023 View  |  Download
Omalizumab biosimilar for treating chronic spontaneous urticaria Omalizumab biosimilar Chronic spontaneous urticaria (CSU) Dermatology 2023 View  |  Download
Omaveloxolone for the treatment of Friedreich's ataxia Omaveloxolone Friedreich's ataxia Genetic Disorders , Neurology 2023 View  |  Download
Ondansetron for treating alcohol use disorder Ondansetron (Setrodon;TO-2061;AD04) Alcohol use disorder Mental and Behavioural Health 2023 View  |  Download
Opicapone adjuvant for the treatment of idiopathic Parkinson's disease Opicapone (Ongentys) Parkinson's disease Neurology 2023 View  |  Download
Osimertinib + pemetrexed + carboplatin +/ cisplatin as a first line treatment for non-small cell lung cancer with EGFR mutation Carboplatin (Paraplatin) , Cisplatin (Platinol) , Osimertinib (Tagrisso; AZD9291; osimertinib mesylate) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Palbociclib with trastuzumab with or without pertuzumab and endocrine therapy for HR+/HER2+ metastatic breast cancer Palbociclib (Ibrance; PD-0332991) , Trastuzumab (Herceptin; RG-597) Breast cancer Breast Cancer 2023 View  |  Download
1 2 9 10 11 12 13 18 19
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications